146 related articles for article (PubMed ID: 12109061)
1. Herpes simplex virus vectors for the nervous system.
Lilley CE; Branston RH; Coffin RS
Curr Gene Ther; 2001 Nov; 1(4):339-58. PubMed ID: 12109061
[TBL] [Abstract][Full Text] [Related]
2. Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo.
Lilley CE; Groutsi F; Han Z; Palmer JA; Anderson PN; Latchman DS; Coffin RS
J Virol; 2001 May; 75(9):4343-56. PubMed ID: 11287583
[TBL] [Abstract][Full Text] [Related]
3. Cellular Antisilencing Elements Support Transgene Expression from Herpes Simplex Virus Vectors in the Absence of Immediate Early Gene Expression.
Han F; Miyagawa Y; Verlengia G; Ingusci S; Soukupova M; Simonato M; Glorioso JC; Cohen JB
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950408
[TBL] [Abstract][Full Text] [Related]
4. Multiple applications for replication-defective herpes simplex virus vectors.
Burton EA; Wechuck JB; Wendell SK; Goins WF; Fink DJ; Glorioso JC
Stem Cells; 2001; 19(5):358-77. PubMed ID: 11553845
[TBL] [Abstract][Full Text] [Related]
5. Gene transfer to neurons using herpes simplex virus-based vectors.
Fink DJ; DeLuca NA; Goins WF; Glorioso JC
Annu Rev Neurosci; 1996; 19():265-87. PubMed ID: 8833444
[TBL] [Abstract][Full Text] [Related]
6. Gene delivery using herpes simplex virus vectors.
Burton EA; Fink DJ; Glorioso JC
DNA Cell Biol; 2002 Dec; 21(12):915-36. PubMed ID: 12573050
[TBL] [Abstract][Full Text] [Related]
7. Construction and packaging of herpes simplex virus/adeno-associated virus (HSV/AAV) Hybrid amplicon vectors.
Saydam O; Glauser DL; Fraefel C
Cold Spring Harb Protoc; 2012 Mar; 2012(3):352-6. PubMed ID: 22383640
[TBL] [Abstract][Full Text] [Related]
8. Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors.
Scarpini CG; May J; Lachmann RH; Preston CM; Dunnett SB; Torres EM; Efstathiou S
Gene Ther; 2001 Jul; 8(14):1057-71. PubMed ID: 11526453
[TBL] [Abstract][Full Text] [Related]
9.
Watson ZL; Washington SD; Phelan DM; Lewin AS; Tuli SS; Schultz GS; Neumann DM; Bloom DC
J Virol; 2018 Aug; 92(16):. PubMed ID: 29875240
[TBL] [Abstract][Full Text] [Related]
10. Latency Entry of Herpes Simplex Virus 1 Is Determined by the Interaction of Its Genome with the Nuclear Environment.
Maroui MA; Callé A; Cohen C; Streichenberger N; Texier P; Takissian J; Rousseau A; Poccardi N; Welsch J; Corpet A; Schaeffer L; Labetoulle M; Lomonte P
PLoS Pathog; 2016 Sep; 12(9):e1005834. PubMed ID: 27618691
[TBL] [Abstract][Full Text] [Related]
11. Adeno-associated Virus Vectors Efficiently Transduce Mouse and Rabbit Sensory Neurons Coinfected with Herpes Simplex Virus 1 following Peripheral Inoculation.
Watson ZL; Ertel MK; Lewin AS; Tuli SS; Schultz GS; Neumann DM; Bloom DC
J Virol; 2016 Sep; 90(17):7894-901. PubMed ID: 27334582
[TBL] [Abstract][Full Text] [Related]
12. HSV trafficking and development of gene therapy vectors with applications in the nervous system.
Frampton AR; Goins WF; Nakano K; Burton EA; Glorioso JC
Gene Ther; 2005 Jun; 12(11):891-901. PubMed ID: 15908995
[TBL] [Abstract][Full Text] [Related]
13. Overview of gene delivery into cells using HSV-1-based vectors.
Neve RL
Curr Protoc Neurosci; 2012 Oct; Chapter 4():Unit 4.12. PubMed ID: 23093351
[TBL] [Abstract][Full Text] [Related]
14. Biosafety of gene therapy vectors derived from herpes simplex virus type 1.
Lim F; Khalique H; Ventosa M; Baldo A
Curr Gene Ther; 2013 Dec; 13(6):478-91. PubMed ID: 24397529
[TBL] [Abstract][Full Text] [Related]
15. Long-term transgene expression in mice infected with a herpes simplex virus type 1 mutant severely impaired for immediate-early gene expression.
Marshall KR; Lachmann RH; Efstathiou S; Rinaldi A; Preston CM
J Virol; 2000 Jan; 74(2):956-64. PubMed ID: 10623758
[TBL] [Abstract][Full Text] [Related]
16. Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous system.
Palmer JA; Branston RH; Lilley CE; Robinson MJ; Groutsi F; Smith J; Latchman DS; Coffin RS
J Virol; 2000 Jun; 74(12):5604-18. PubMed ID: 10823868
[TBL] [Abstract][Full Text] [Related]
17. Spread and replication of and immune response to gamma134.5-negative herpes simplex virus type 1 vectors in BALB/c mice.
Broberg EK; Peltoniemi J; Nygårdas M; Vahlberg T; Röyttä M; Hukkanen V
J Virol; 2004 Dec; 78(23):13139-52. PubMed ID: 15542666
[TBL] [Abstract][Full Text] [Related]
18. Replication of herpes simplex virus type 1 within trigeminal ganglia is required for high frequency but not high viral genome copy number latency.
Thompson RL; Sawtell NM
J Virol; 2000 Jan; 74(2):965-74. PubMed ID: 10623759
[TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus vectors for gene delivery to a variety of different cell types.
Latchman DS
Curr Gene Ther; 2002 Dec; 2(4):415-26. PubMed ID: 12477253
[TBL] [Abstract][Full Text] [Related]
20. Herpes simplex virus type 1/adeno-associated virus hybrid vectors mediate site-specific integration at the adeno-associated virus preintegration site, AAVS1, on human chromosome 19.
Heister T; Heid I; Ackermann M; Fraefel C
J Virol; 2002 Jul; 76(14):7163-73. PubMed ID: 12072516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
